Unknown

Dataset Information

0

Activatable clinical fluorophore-quencher antibody pairs as dual molecular probes for the enhanced specificity of image-guided surgery.


ABSTRACT: The emergence of fluorescently labeled therapeutic antibodies has given rise to molecular probes for image-guided surgery. However, the extraneous interstitial presence of an unbound and nonspecifically accumulated probe gives rise to false-positive detection of tumor tissue and margins. Thus, the concept of tumor-cell activation of smart probes provides a potentially superior mechanism of delineating tumor margins as well as small tumor deposits. The combination of molecular targeting with intracellular activation circumvents the presence of extracellular, nonspecific signals of targeted probe accumulation. Here, we present a demonstration of the clinical antibodies cetuximab (cet, anti-EGFR mAb) and trastuzumab (trast, anti-HER-2 mAb) conjugated to Alexa Fluor molecules and IRDye QC-1 quencher optimized at the ratio of 1?2?6 to provide the greatest degree of proteolytic fluorescence activation, synonymous with intracellular lysosomal degradation. The cet-AF-Q-C1 conjugate (1?2?6) provides up to 9.8-fold proteolytic fluorescence activation. By preparing a spectrally distinct, irrelevant sham IgG-AF-QC-1 conjugate, a dual-activatable probe approach is shown to enhance the specificity of imaging within an orthotopic AsPC-1 pancreatic cancer xenograft model. The dual-activatable approach warrants expedited clinical translation to improve the specificity of image-guided surgery by spectrally decomposing specific from nonspecific probe accumulation, binding, and internalization.

SUBMITTER: Obaid G 

PROVIDER: S-EPMC5574035 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5628680 | BioStudies
2014-01-01 | S-EPMC3944097 | BioStudies
2020-01-01 | S-EPMC6978336 | BioStudies
2015-01-01 | S-EPMC5575776 | BioStudies
2019-01-01 | S-EPMC6467920 | BioStudies
1000-01-01 | S-EPMC5706095 | BioStudies
1000-01-01 | S-EPMC2596150 | BioStudies
2018-01-01 | S-EPMC6096399 | BioStudies
1000-01-01 | S-EPMC5701610 | BioStudies
1000-01-01 | S-EPMC4445874 | BioStudies